Widschwendter, Christian G.
Kemmler, Georg
Rettenbacher, Maria A.
Yalcin-Siedentopf, Nursen
Hofer, Alex
Article History
Received: 25 January 2018
Accepted: 12 June 2018
First Online: 28 June 2018
Ethics approval and consent to participate
: All procedures contributing to this work complied with the standards of the Ethics Committee of Medical University Innsbruck and were conducted according to Good Clinical Practice standards on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008.
: No patient identifiable information has been reported.
: Christian Widschwendter, Georg Kemmler, and Nursen Yalcin-Siedentopf have no actual or potential conflict of interest. Maria A. Rettenbacher is member of a advisory board of Eli Lilly and has received speaker’s or consultancy fees from Eli Lilly. Alex Hofer has received a research grant from Janssen-Cilag. He has received speaker’s or consultancy fees from Bristol-Myers Squibb, Janssen-Cilag and Lundbeck as well as reimbursements for travel and meeting expenses from Janssen-Cilag and Lundbeck.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.